EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The WWP1–JARID1B axis sustains acute myeloid leukemia chemoresistance

Claudia Fierro iD, Sara Giovannini iD, Valeria Moriconi iD, Claudia Fiorilli iD, Emanuele Panatta iD, Valentina Frezza iD, Federica Corigliano, Rosalba Pecorari, Yanan Li, Ji Zhou iD, Vincenza Simona Delvecchio, Artem Smirnov iD und 8 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2421159122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Claudia Fierro und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Ubiquitin-Protein Ligases, Jumonji Domain-Containing Histone Demethylases, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondazione AIRC per la ricerca sul cancro ETS (AIRC), MUR-PNRR M4C2I1.3 PE6.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To uncover substrates mediating the oncogenic activity of WWP1 in acute myeloid leukemia (AML), we performed a proteomic analysis that identified the histone demethylase KDM5B /JARID1B as a candidate target. Of note, JARID1B is indispensable for efficient recruitment of several DNA damage repair factors and for damage resolution, thus negatively influencing the sensitivity of cancer cells to chemo- and radiation therapies. Validation of JARID1B as a substrate of WWP1 revealed a positive regulation of JARID1B half-life by WWP1 through the establishment of K63-linked polyubiquitin chains. As a result, downregulation of JARID1B rising from WWP1 inactivation was associated with higher H3K4me3 enrichment at JARID1B target genes in WWP1-depleted relatively to control AML cells. Integration of RNA-seq and H3K4me3 ChIP-seq data uncovered a highly significant overlap between upregulated gene expression and enriched H3K4me3 peaks after shWWP1 inactivation. We confirmed transcriptional activation of JARID1B targets in WWP1-depleted cells, supporting a role for WWP1 in regulating JARID1B activity. Coherently, upon WWP1 inactivation, we observed a defective recruitment of repair proteins after DNA damage, with subsequent reduced DNA damage repair efficiency and enhanced sensitization of AML cells to the cytotoxic activity of chemotherapeutic drugs. All together, these data identify JARID1B as a bona fide target of WWP1 and imply that WWP1-mediated regulation of JARID1B impacts its ability to modify chromatin and to recruit DNA damage repair factors, thus ultimately affecting chemosensitivity of AML cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteUbiquitin-Protein LigasesJumonji Domain-Containing Histone DemethylasesDrug Resistance, NeoplasmRepressor ProteinsHumansCell Line, TumorHistonesDNA DamageNuclear Proteins

Stichwörter der Autor:innen

DNA repairacute myeloid leukemiaprotein degradationprotein ubiquitination

Substanzen

Ubiquitin-Protein LigasesJumonji Domain-Containing Histone DemethylasesKDM5B protein, humanRepressor ProteinsHistonesNuclear Proteins

Autor:innen und Institutionen

  • Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy.
  • Biochemistry Laboratory, Istituto Dermopatico Immacolata, Rome 00100, Italy.
  • The First Affiliated Hospital of Soochow University, Institutes for Translational Medicine, Soochow University, Suzhou 215000, China.
  • Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu 215000, China.
  • Center for Omics Sciences, Istituti di Ricovero e Cura a Carattere Scientifico, San Raffaele Scientific Institute, Milan 20132, Italy.
  • Lymphoid stromal cell biology Unit, Division of Experimental Oncology, Istituti di Ricovero e Cura a Carattere Scientifico, San Raffaele Scientific Institute, Milan 20132, Italy.

ORCID-Profile: Claudia Fierro, Sara Giovannini, Valeria Moriconi, Claudia Fiorilli, Emanuele Panatta, Valentina Frezza, Ji Zhou, Artem Smirnov, Jose Manuel Garcia Manteiga, Eleonora Candi, Gerry Melino, Francesca Bernassola

Förderung

  • Fondazione AIRC per la ricerca sul cancro ETS (AIRC)
  • MUR-PNRR M4C2I1.3 PE6

Zitieren

APA

Fierro, C., Giovannini, S., Moriconi, V., Fiorilli, C., Panatta, E., Frezza, V., Corigliano, F., Pecorari, R., Li, Y., Zhou, J., Delvecchio, V. S., Smirnov, A., Manteiga, J. M. G., Brendolan, A., Zhang, J., Shi, Y., Amelio, I., Candi, E., Melino, G., & Bernassola, F. (2025). The WWP1–JARID1B axis sustains acute myeloid leukemia chemoresistance. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2421159122

Vancouver

Fierro C, Giovannini S, Moriconi V, Fiorilli C, Panatta E, Frezza V, et al. The WWP1–JARID1B axis sustains acute myeloid leukemia chemoresistance. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2421159122

BibTeX
@article{Fierro2025,
  author = {Fierro, Claudia and Giovannini, Sara and Moriconi, Valeria and Fiorilli, Claudia and Panatta, Emanuele and Frezza, Valentina and Corigliano, Federica and Pecorari, Rosalba and Li, Yanan and Zhou, Ji and Delvecchio, Vincenza Simona and Smirnov, Artem and Manteiga, Jose Manuel Garcia and Brendolan, Andrea and Zhang, Jinping and Shi, Yufang and Amelio, Ivano and Candi, Eleonora and Melino, Gerry and Bernassola, Francesca},
  title = {The WWP1–JARID1B axis sustains acute myeloid leukemia chemoresistance},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2421159122}
}
Kostenlos starten →